Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$789M |
| 3 |
Amazon
AMZN
|
+$651M |
| 4 |
NVIDIA
NVDA
|
+$442M |
| 5 |
Tesla
TSLA
|
+$423M |
Top Sells
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
Aon
AON
|
+$184M |
| 3 |
JD.com
JD
|
+$173M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$139M |
Sector Composition
| 1 | Technology | 26.23% |
| 2 | Healthcare | 13.24% |
| 3 | Financials | 12.99% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FATBB
3701
FAT Brands
FATBB
$45.9M
| $1.05M | ﹤0.01% |
+122,276
| New | +$1.05M |
|
3702
GH Research
GHRS
$800M
| $1.04M | ﹤0.01% |
44,633
+17,435
| +64% | +$407K |
|
3703
ORIX
IX
$29.8B
| $1.04M | ﹤0.01% |
50,985
-2,005
| -4% | -$40.8K |
|
3704
Immunome
IMNM
$783M
| $1.04M | ﹤0.01% |
79,968
+25,299
| +46% | +$328K |
|
3705
Rani Therapeutics
RANI
$23.3M
| $1.03M | ﹤0.01% |
63,217
+41,578
| +192% | +$679K |
|
3706
Schwab International Equity ETF
SCHF
$50.9B
| – | – |
0
| – | -$1.03M |
|
3707
Union Bankshares
UNB
$117M
| $1.03M | ﹤0.01% |
35,546
| – | – |
|
|
AUTL
3708
Autolus Therapeutics
AUTL
$367M
| $1.03M | ﹤0.01% |
198,485
+135,956
| +217% | +$706K |
|
3709
inTEST
INTT
$88.6M
| $1.03M | ﹤0.01% |
80,880
| – | – |
|
|
OMCC
3710
Old Market Capital Corporation Common Stock
OMCC
$35.8M
| $1.03M | ﹤0.01% |
87,190
-300
| -0.3% | -$3.53K |
|
3711
Acme United Corp
ACU
$159M
| $1.03M | ﹤0.01% |
30,430
| – | – |
|
|
ZYNE
3712
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.02M | ﹤0.01% |
355,509
+5,737
| +2% | +$16.5K |
|
|
MGIC
3713
Magic Software Enterprises
MGIC
$1.01B
| $1.02M | ﹤0.01% |
48,749
+484
| +1% | +$10.1K |
|
|
OKUR
3714
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.8M
| $1.02M | ﹤0.01% |
11,924
-143
| -1% | -$12.2K |
|
3715
Kaltura
KLTR
$255M
| $1.02M | ﹤0.01% |
302,345
+57,598
| +24% | +$194K |
|
|
HUT
3716
Hut 8
HUT
$3.27B
| $1.01M | ﹤0.01% |
25,779
+2,913
| +13% | +$114K |
|
3717
NRX Pharmaceuticals
NRXP
$70.6M
| $1.01M | ﹤0.01% |
21,150
+16,573
| +362% | +$791K |
|
3718
Surrozen
SRZN
$101M
| $1.01M | ﹤0.01% |
10,448
+1,879
| +22% | +$181K |
|
3719
Actinium Pharmaceuticals
ATNM
$50.2M
| $1M | ﹤0.01% |
167,172
| – | – |
|
|
CGAU
3720
Centerra Gold
CGAU
$1.82B
| $1M | ﹤0.01% |
115,138
+26,228
| +29% | +$228K |
|
3721
Orion Group Holdings
ORN
$295M
| $1M | ﹤0.01% |
265,703
-1,016
| -0.4% | -$3.83K |
|
3722
Graham Corp
GHM
$530M
| $999K | ﹤0.01% |
80,361
| – | – |
|
|
SUP
3723
DELISTED
Superior Industries International
SUP
| $996K | ﹤0.01% |
222,530
+4,684
| +2% | +$21K |
|
3724
Plumas Bancorp
PLBC
$313M
| $995K | ﹤0.01% |
29,460
| – | – |
|
3725
Genie Energy
GNE
$400M
| $993K | ﹤0.01% |
178,450
| – | – |
|